Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
121.11
-0.61 (-0.50%)
Nov 12, 2026, 1:44 PM EST - Market open

Hinge Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Revenue
800.82587.86390.4292.73
Revenue Growth
49.86%50.58%33.37%-
Gross Profit
687.05469.3300.59194.18
Operating Income
149.7-546.37-31.22-130.51
Net Income
374.61-424.09-11.93-108.14
Earnings Per Share
1.99-7.77-0.88-8.31
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
354.2477.03466.57423.36
Total Debt
33.888.0411.0715.73
Net Cash (Debt)
320.32469455.5407.62
Net Cash Growth
-34.10%2.96%11.74%-
Net Cash Per Share
3.828.5933.6031.31

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
322.99171.4449-63.91
Capital Expenditures
-10.03-0.71-1.04-1.98
Free Cash Flow
312.97170.7347.96-65.89
Free Cash Flow Growth
115.20%255.97%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Gross Margin
85.79%79.83%77.00%66.33%
Operating Margin
18.69%-92.94%-8.00%-44.59%
Pretax Margin
20.77%-89.69%-2.88%-37.08%
Profit Margin
46.78%-72.14%-3.06%-36.94%
FCF Margin
39.08%29.04%12.29%-22.51%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
Forward PE
41.2430.32--
P/FCF Ratio
31.2721.42--
PS Ratio
12.226.22--